Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases
Authors
Keywords
Cervical cancer, Primary tumor, Metastatic lymph nodes, Classical and non-classical HLA expression, Squamous cell carcinoma, Adenocarcinoma
Journal
Journal for ImmunoTherapy of Cancer
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-11
DOI
10.1186/s40425-016-0184-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human Leukocyte Antigen-DR Expression is Significantly Related to an Increased Disease-Free and Disease-Specific Survival in Patients With Cervical Adenocarcinoma
- (2016) Sanne Samuels et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix
- (2016) A Marijne Heeren et al. MODERN PATHOLOGY
- FoxP3+ and IL-17+ cells are correlated with improved prognosis in cervical adenocarcinoma
- (2015) Simone Punt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma
- (2015) S. Samuels et al. TISSUE ANTIGENS
- Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome
- (2015) Vivian M. Spaans et al. PLoS One
- Human Leukocyte Antigen E Contributes to Protect Tumor Cells from Lysis by Natural Killer Cells
- (2015) Elisa Lo Monaco et al. NEOPLASIA
- Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy
- (2014) Jenny Ling-Yu Chen et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- KIR2DL4 Differentially Signals Downstream Functions in Human NK Cells through Distinct Structural Modules
- (2014) S. M. Shahjahan Miah et al. JOURNAL OF IMMUNOLOGY
- Cervical Cancer Cell Supernatants Induce a Phenotypic Switch from U937-Derived Macrophage-Activated M1 State into M2-Like Suppressor Phenotype with Change in Toll-Like Receptor Profile
- (2014) Karina Sánchez-Reyes et al. Biomed Research International
- HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas
- (2014) M. J. Rutten et al. Journal of Immunology Research
- Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma
- (2014) Mahboobeh Safaeian et al. Frontiers in Oncology
- Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
- (2013) E C M Zeestraten et al. BRITISH JOURNAL OF CANCER
- Oncogenic mutations in cervical cancer
- (2013) Alexi A. Wright et al. CANCER
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma
- (2013) Ana B. del Campo et al. INTERNATIONAL JOURNAL OF CANCER
- HLA-E expression in cervical adenocarcinomas: association with improved long-term survival
- (2012) Vivian M Spaans et al. Journal of Translational Medicine
- Immunotherapy eradicates metastases with reversible defects in MHC class I expression
- (2011) Cristina Garrido et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer
- (2011) Marlies Schrevel et al. MODERN PATHOLOGY
- Altered HLA Class I and HLA-G Expression Is Associated with IL-10 Expression in Patients with Cervical Cancer
- (2011) Josefa Antonia Rodríguez et al. PATHOBIOLOGY
- HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes
- (2011) M. Gooden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions
- (2010) Federico Garrido et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer
- (2010) E. M. de Kruijf et al. CLINICAL CANCER RESEARCH
- A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB–IIA
- (2010) Yoo-Young Lee et al. GYNECOLOGIC ONCOLOGY
- Low Expression of Human Histocompatibility Soluble Leukocyte Antigen-G (HLA-G5) in Invasive Cervical Cancer With and Without Metastasis, Associated With Papilloma Virus (HPV)
- (2009) Marcia C.M. Guimarães et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Lymph node assessment in cervical cancer: Prognostic and therapeutic implications
- (2009) L.T. Gien et al. JOURNAL OF SURGICAL ONCOLOGY
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?
- (2008) E. S. Jordanova et al. CLINICAL CANCER RESEARCH
- Classical and non-classical HLA molecules and p16INK4a expression in precursors lesions and invasive cervical cancer
- (2008) Maria Alice G. Gonçalves et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started